Patients’ Knowledge and Perspectives on Vitamin K Antagonists for Stroke Prevention in Atrial Fibrillation: Implications for Treatment Quality

Anatolian journal of cardiology - Turkey
doi 10.14744/anatoljcardiol.2017.7980
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Kare Publishing

Related search

Role of Non-Vitamin K Oral Anticoagulants for Prevention of Stroke in Renal Impaired Atrial Fibrillation Patients

ACI (Acta Cardiologia Indonesiana)
2019English

Transient Ischemic Attacks in Patients With Atrial Fibrillation: Implications for Secondary Prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2004English

Left Atrial Appendage Exclusion for Stroke Prevention in Atrial Fibrillation

Cardiology Research and Practice
Cardiovascular MedicineCardiology
2012English

Stroke Prevention in Atrial Fibrillation

Journal of Atrial Fibrillation
Cardiovascular MedicineCardiology
2010English

Stroke Prevention in Atrial Fibrillation

International Journal of Arrhythmia
2017English

Pcv79 - Real-World Cost-Effectiveness of Rivaroxaban Compared With Vitamin K Antagonists in the Context of Stroke Prevention in Atrial Fibrillation in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Exposure to Vitamin K Antagonists and Kidney Function Decline in Patients With Atrial Fibrillation and Chronic Kidney Disease

Research and Practice in Thrombosis and Haemostasis
2019English

Stroke Detection and Prevention in Atrial Fibrillation

British Journal of General Practice
MedicineFamily Practice
2015English

Stroke Prevention in Atrial Fibrillation Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy